Literature DB >> 17701145

[Psychosocial factors in psoriasis. A pilot study].

J A Bahmer1, F Petermann, J Kuhl.   

Abstract

BACKGROUND: The successful treatment of patients with chronic plaque psoriasis depends not only on the method of therapy but also on psychosocial factors. METHODS AND
RESULTS: A pilot study was performed on 22 patients with chronic plaque psoriasis. The psychosocial stress, psychiatric features and their changes were assessed over a 3-week inpatient rehabilitation stay in a specialty clinic. The severity of the psoriasis, the subjective degree of suffering and the psychometric variables related to psychosomatic symptoms were assessed before and at the end of the treatment. After the hospitalization, the severity of disease and anger were both significantly decreased, along with an increased interest in social interactions.
CONCLUSION: In psoriasis patients, one can distinguish between different psychosocial factors, some of which are more likely to change. Stable attributes such as personality style can impact on compliance as well as on coping behaviors, thereby influencing treatment success. Our study shows that even within a rather short inpatient treatment period of 3 weeks not only the disease severity but also negative psychosocial stressors can be improved.

Entities:  

Mesh:

Year:  2007        PMID: 17701145     DOI: 10.1007/s00105-007-1371-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  32 in total

1.  The natural history of psoriasis in 5,600 patients.

Authors:  E M Farber; M L Nall
Journal:  Dermatologica       Date:  1974

2.  Use of a support group for dermatologic patients.

Authors:  B A Lombardo; L A Cave; S Naso
Journal:  Cutis       Date:  1988-02

Review 3.  The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

Review 4.  Genetic aspects of psoriasis.

Authors:  J N Barker
Journal:  Clin Exp Dermatol       Date:  2001-06       Impact factor: 3.470

5.  A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy.

Authors:  D G Fortune; H L Richards; B Kirby; S Bowcock; C J Main; C E M Griffiths
Journal:  Br J Dermatol       Date:  2002-03       Impact factor: 9.302

Review 6.  Medical backgrounder: psoriasis.

Authors:  Lisa Travis; Jeffrey M Weinberg
Journal:  Drugs Today (Barc)       Date:  2002-12       Impact factor: 2.245

7.  Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.

Authors:  Dorothea M Sommer; Stefan Jenisch; Michael Suchan; Enno Christophers; Michael Weichenthal
Journal:  Arch Dermatol Res       Date:  2006-09-22       Impact factor: 3.017

Review 8.  A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis.

Authors:  C M Owen; R J Chalmers; T O'Sullivan; C E Griffiths
Journal:  Br J Dermatol       Date:  2001-12       Impact factor: 9.302

Review 9.  The use of ciclosporin in psoriasis: a clinical review.

Authors:  V C Ho
Journal:  Br J Dermatol       Date:  2004-05       Impact factor: 9.302

10.  Alcohol intake: a risk factor for psoriasis in young and middle aged men?

Authors:  K Poikolainen; T Reunala; J Karvonen; J Lauharanta; P Kärkkäinen
Journal:  BMJ       Date:  1990-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.